Prevalence and severity of cutaneous manifestations in patients of CRF on hemodialysis in relation to duration of replacement therapy

Authors

  • Sumara Rashid Fatima Memorial College of Medicine & Dentistry, Shadman, Lahore
  • Saleha Azeem King Edward Medical University, Lahore
  • Zaib Sargodha Medical College, Sargodha
  • Usma Iftikhar King Edward Medical University, Lahore
  • Uzma Sarwar Shalamar Medical and Dental College, Lahore
  • Aliya Akhtar Nishtar Medical University, Multan

DOI:

https://doi.org/10.66344/jpad.v31i2.1764

Abstract

Objective To determine the effect of duration of HD on the prevalence and severity of different cutaneous manifestations of ESRD.

 

Methods 100 patients of ESRD at Fatima Memorial Hospital, Shadman were randomly enrolled and analyzed for multiple cutaneous manifestations over a period of eight months. The severity of these manifestations as mild, moderate, severe or very severe and their prevalence along with other particulars and time duration of HD was recorded in addition to any co-morbidities these patients had. Data was organized into tables and graphs.

 

Results Out of 100 patients, 82% had xerosis, 69% had pruritus, 66% had pigmentary changes, 34% had nail changes, 15% had perforating dermatosis, 10% had bullous lesions, 30% had generalized hair loss and 7% had eczematization at the site of fistula. Out of 100 patients, 46% had severe xerosis, 19% had severe pruritus, 17% had severe pigmentary changes, 31% had severe nail changes, 14% had severe perforating dermatosis, no patients with bullous lesions fell in the category of severe disorder, 12% had severe hair loss and 4% had severe eczematization. The rest had mild and moderate forms of the disease.

 

Conclusion Cutaneous manifestations among HD patients are common and most of them increase with an increase in the duration of HD. Coordination between a patient’s dermatologist and nephrologist can optimize their health experience.

 

 

Author Biographies

  • Sumara Rashid, Fatima Memorial College of Medicine & Dentistry, Shadman, Lahore

    Department of Dermatology

  • Saleha Azeem, King Edward Medical University, Lahore

    1st Year MBBS

  • Zaib, Sargodha Medical College, Sargodha

    Department of Dermatology

  • Usma Iftikhar, King Edward Medical University, Lahore

    PhD. Scholar

  • Uzma Sarwar, Shalamar Medical and Dental College, Lahore

    Department of Dermatology

  • Aliya Akhtar, Nishtar Medical University, Multan

    Department of Dermatology

References

1. Bouhamidi A, El Amraoui M, Rafik H, Boui M, Hjira N. Dermatologic Manifestations in Patients on Chronic Hemodialysis. J Dermatol Res Ther. 2019;5:069. doi.org/10.23937/2469-5750/1510069

2. Anees M, Butt G, Gull S, et al. Factors Affecting Dermatological Manifestations in Patients with End Stage Renal Disease. J Coll Physicians Surg Pak. 2018;28(2):98-102. DOI: 10.29271/jcpsp.2018.02.98

3. Udayakumar P, Balasubramanian S, Ramalingam K S, Lakshmi C, Srinivas C R, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol. 2006;72:119-25

4. Ullah K, Butt G, Masroor I, Kanwal K, Kifayat F. Epidemiology of chronic kidney disease in a Pakistani population. Saudi J Kidney Dis Transpl 2015;26:1307-10

5. Markova, A., Lester, J., Wang, J., & Robinson‐Bostom, L. (2012). Diagnosis of common dermopathies in dialysis patients: a review and update. Seminars in Dialysis. 2012;25(4):408-18.

6. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihyper-tensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5):S1-290.

7. Fraser, S.D.S., Roderick, P.J., May, C.R. et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16:193.

8. Galperin, Timur A et al. “Cutaneous manifestations of ESRD.” CJASN, 2014; 9(1): 201-18. doi:10.2215/CJN.05900513

9. Shirazian S, Aina O, Park Y, Chowdhury N, Leger K, Hou L, Miyawaki N, Mathur VS. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis. 2017;10:11-26. doi: 10.2147/IJNRD.S108045. PMID: 28176969; PMCID: PMC5271405.

10. Tapia L. Pruritus on hemodialysis. Int J Dermatol. 1979;18:217–8.

11. Szepietowski, Jacek & Reich, Adam & Schwartz, Robert. Uraemic xerosis. Nephrology Dialysis Transplantation. 2004;19(11):2709-12.

12. Tercedor J, Hernandez BL, Rodenas JM. Nail diseases in hemodialysis patients: Case-control study. Br J Dermatol. 2001;144:415-48.

13. Pico MR, Lugo-Somolinos A, Sánchez JL, Burgos-Calderón R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol. 1992;31:860–3.

14. Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996;11:2031–6.

15. Mirza R, Wahid Z, Talat H. Dermatological manifestations in chronic renal failure patients on hemodialysis, JLliaq Univ Hel Scic. 2012;11:22-8.

16. Masmoudi A, Darouiche MH, Salah HB, Hmida MB, Turki H. Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patients. J Dermatol Case Rep. 2014;8:86-94.

17. Sultan MM, Mansour HM, Wahby IM, Ali S Houddy. Cutaneous manifestations in Egyptian patients with chronic renal failure on regular haemodialysis. J Egypt Women Dermtal Soc. 2009;7-1.

18. Mourad B, Hegab D, Okasha K, Rizk S. Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt. Clin Cosmet Investig Dermatol. 2014;7:313–9. Published 2014 Nov 11. doi:10.2147/CCID.S70842

19. Abdelbaqi‑Salhab M, Shalhub S, Morgan MB. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003;30:527‑38.

20. Lupi O, Rezende L, Zangrando M, Sessim M, Silveira CB, Sepulcri MA, et al. Cutaneous manifestations in end stage renal disease. An Bras Dermatol. 2011;86:319‑26.

Downloads

Published

06.08.2021

Issue

Section

Original Articles

How to Cite

1.
Prevalence and severity of cutaneous manifestations in patients of CRF on hemodialysis in relation to duration of replacement therapy. J Pak Assoc Dermatol [Internet]. 2021 Aug. 6 [cited 2026 Sep. 17];31(2):224-30. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1764